Is your child currently experiencing CD flare-ups? Local medical research study is testing a potential new medication to see if it may reduce cramping, failure to thrive, abdominal pain, malnutrition, and/or anemia associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for teen to join a Crohn’s disease research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderately to severely active ulcerative colitis (including associated symptoms such as chronic diarrhea, perianal fistula, cramps, weight loss and/or canker sores), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce recurrent diarrhea, inflammation of the bowel or intestine, rectal pain, frequent fevers, and/or canker sores associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for children 2–17 years old to join a Crohn’s disease trial to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderately to severely active IBD (including associated symptoms such as tiredness, loss of appetite, diarrhea, frequent fevers and/or anemia), consider one of our Crohn’s disease (CD) research. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing UC flare-ups? Local CD research study is testing a potential new medication to see if it may reduce stomach pain, mouth sores, constant need to poop, chronic fatigue, and/or eye pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for teen to join a Crohn’s disease (CD) research to help us discover more about treating IBD. If you are looking for a potential new treatment option for IBD or ulcerative colitis (UC) (including associated symptoms such as abdominal cramps, abdominal cramps, diarrhea, weight loss and/or liver disease), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your teen may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce recurrent diarrhea, inflammation of the bowel or intestine, abdominal pain, frequent fevers, and/or canker sores associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease clinical trial to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or IBD (including associated symptoms such as chronic diarrhea, abdominal cramps, constant need to poop, chronic fatigue and/or anemia), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce swollen joints, iron deficiency, cramps, chronic fatigue, and/or joint pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children aged 2 to 17 years to join a medical research study to help us discover more about treating moderate to severe IBD. If you are looking for a potential new treatment option for moderate to severe IBD or IBD (including associated symptoms such as fatigue, blood in the stool, constant need to poop, malnutrition and/or eye pain), consider one of our CD and UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the CD and UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.